Valuation: Ibnsina Pharma

Market Cap 13.18B 263M 227M 213M 194M 364M 25.12B 369M 2.49B 977M 12.59B 986M 965M 41.86B P/E 2026 *
10.7x
P/E 2027 * 7.35x
Enterprise Value 19B 379M 327M 307M 279M 525M 36.2B 532M 3.59B 1.41B 18.14B 1.42B 1.39B 60.33B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.19x
Free-Float
70.08%
Yield 2026 *
2.29%
Yield 2027 * 4.43%
1 day-3.47%
1 week-5.08%
Current month+15.04%
1 month+13.74%
3 months+11.32%
6 months+4.56%
Current year+11.60%
1 week 13.05
Extreme 13.05
16
1 month 11.3
Extreme 11.3
16.93
Current year 9.63
Extreme 9.63
16.93
1 year 9.63
Extreme 9.63
16.93
3 years 1.78
Extreme 1.78
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 18/12/2000
Chief Executive Officer - 18/12/2000
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 18/12/2000
Director/Board Member - 18/12/2000
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-3.47%-5.08%+23.28%+500.00% 262M
-0.96%+0.46%-36.13%-22.61% 16.05B
+1.08%-8.38%-38.46%-37.16% 6.68B
-1.53%-0.48%-23.01%-19.25% 6.22B
-0.12%+8.35%+2.70%-26.36% 4.32B
-0.05%-2.57%-19.13%-39.69% 3.22B
-1.77%-2.51%-43.84%-23.17% 3.04B
-0.78%+1.48%+4.28%-38.72% 3.02B
+0.22%-0.20%-13.06%-1.04% 2.64B
-1.31%-8.69%+52.56% - 2.43B
Average -0.87%-4.28%-9.08%+32.44% 4.79B
Weighted average by Cap. -0.62%-2.30%-21.94%-22.70%

Financials

2026 *2027 *
Net sales 89.87B 1.79B 1.55B 1.45B 1.32B 2.48B 171B 2.52B 17B 6.66B 85.79B 6.72B 6.58B 285B 101B 2.02B 1.74B 1.63B 1.49B 2.8B 193B 2.84B 19.14B 7.5B 96.59B 7.57B 7.41B 321B
Net income 1.33B 26.44M 22.82M 21.41M 19.5M 36.67M 2.53B 37.18M 251M 98.36M 1.27B 99.25M 97.1M 4.21B 1.92B 38.35M 33.11M 31.06M 28.29M 53.2M 3.67B 53.94M 364M 143M 1.84B 144M 141M 6.11B
Net Debt 5.82B 116M 100M 93.88M 85.51M 161M 11.08B 163M 1.1B 431M 5.55B 435M 426M 18.47B 5.77B 115M 99.29M 93.15M 84.85M 160M 11B 162M 1.09B 428M 5.51B 432M 422M 18.33B
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
16/08/26 EGP 13.08 -3.47% 8,719,401
13/08/26 EGP 13.55 -0.73% 8,419,183
12/08/26 EGP 13.65 -2.50% 7,723,539
11/08/26 EGP 14.00 -3.78% 38,925,548
10/08/26 EGP 14.55 +5.59% 28,273,396
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.08EGP
Average target price
17.26EGP
Spread / Average Target
+31.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPH Stock